Strata Oncology

📍 Ann Arbor, United States👥 56 employees💰 Last funded Dec 2018
Strata Oncology is a high-growth, state-of-the art, precision oncology company, delivering a new standard of care that integrates molecular profiling, decision support and clinical trial participation into routine practice. We do this by partnering with major healthcare systems across the country, who systematically send their cancer patients’ biopsies to our high-throughput CLIA lab for genomic sequencing, with results provided to the oncologist within days, indicating the tumor profile, and matches to appropriate therapies and drug trials. This accelerates the move to personalized medicine – right medicines to the right patients at the right time. Our personnel are passionate about and committed to making a positive difference, now, in the lives of cancer patients and their families. Clinicians, pathologists, bioinformaticists, software engineers, lab technicians and more, coming together to give access to those without, uncovering insight that might be hidden, all while spreading urgency to all. Experience a career that connects a fast-paced team environment with a worthy pursuit – feel good about what you’ve accomplished at the end of every day!
3
Total investors
0
Early stage
0
Mid stage
0
Late stage
Founded
Investor geography1 country
United States
3
Investor activity2016–2018 · investors recorded per year
2016220181
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Strata Oncology?
Strata Oncology has 3 investors on record on gritt.io.
When did Strata Oncology last raise funding?
The most recent investment in Strata Oncology recorded on gritt.io was in December 2018.
What industry is Strata Oncology in?
Strata Oncology operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Strata Oncology based?
Strata Oncology is headquartered in Ann Arbor, United States.